Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.14p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.53
  • 52 Week Low: 0.12
  • Currency: UK Pounds
  • Shares Issued: 1,320.30m
  • Volume: 1,664,378
  • Market Cap: £1.78m
  • RiskGrade: 435

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
86.41% below the market average86.41% below the market average86.41% below the market average86.41% below the market average86.41% below the market average
84% below the sector average84% below the sector average84% below the sector average84% below the sector average84% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
78.18% above the market average78.18% above the market average78.18% above the market average78.18% above the market average78.18% above the market average
90.00% above the sector average90.00% above the sector average90.00% above the sector average90.00% above the sector average90.00% above the sector average
Price Book Ratio
44.20% above the market average44.20% above the market average44.20% above the market average44.20% above the market average44.20% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
54.55% below the market average54.55% below the market average54.55% below the market average54.55% below the market average54.55% below the market average
6.98% below the sector average6.98% below the sector average6.98% below the sector average6.98% below the sector average6.98% below the sector average
Price Chg 3m
5.38% above the market average5.38% above the market average5.38% above the market average5.38% above the market average5.38% above the market average
6.98% above the sector average6.98% above the sector average6.98% above the sector average6.98% above the sector average6.98% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
98.51% below the market average98.51% below the market average98.51% below the market average98.51% below the market average98.51% below the market average
85.19% below the sector average85.19% below the sector average85.19% below the sector average85.19% below the sector average85.19% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
47.8% below the market average47.8% below the market average47.8% below the market average47.8% below the market average47.8% below the market average
12.82% above the sector average12.82% above the sector average12.82% above the sector average12.82% above the sector average12.82% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
95.57% below the market average95.57% below the market average95.57% below the market average95.57% below the market average95.57% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Operating Profit Loss
63.31% below the market average63.31% below the market average63.31% below the market average63.31% below the market average63.31% below the market average
23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average23.08% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
83.46% below the market average83.46% below the market average83.46% below the market average83.46% below the market average83.46% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average
Cash
67.7% below the market average67.7% below the market average67.7% below the market average67.7% below the market average67.7% below the market average
48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
92.93% below the market average92.93% below the market average92.93% below the market average92.93% below the market average92.93% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.14p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.53
52 Week Low 0.12
Volume 1,664,378
Shares Issued 1,320.30m
Market Cap £1.78m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.65% above the market average34.65% above the market average34.65% above the market average34.65% above the market average34.65% above the market average
84.62% above the sector average84.62% above the sector average84.62% above the sector average84.62% above the sector average84.62% above the sector average
Price Trend
94.76% below the market average94.76% below the market average94.76% below the market average94.76% below the market average94.76% below the market average
86.05% below the sector average86.05% below the sector average86.05% below the sector average86.05% below the sector average86.05% below the sector average
Income Not Available
Growth
0.92% above the market average0.92% above the market average0.92% above the market average0.92% above the market average0.92% above the market average
Sector averageSector averageSector averageSector averageSector average

Valirx Dividends

No dividends found

Trades for 07-Oct-2026

Time Volume / Share Price
15:20 10,000 @ 0.15p
14:07 10,000 @ 0.13p
13:17 200,000 @ 0.13p
12:48 750,000 @ 0.13p
11:27 346,856 @ 0.12p

Valirx Key Personnel

CFO Gerald Desler

Top of Page